Pharma-Bio Serv Price To Earning vs. Operating Margin
| PBSV Stock | USD 0.42 0.09 17.65% |
For Pharma-Bio Serv profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Pharma-Bio Serv to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Pharma Bio Serv utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Pharma-Bio Serv's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Pharma Bio Serv over time as well as its relative position and ranking within its peers.
Pharma-Bio |
Pharma Bio Serv Operating Margin vs. Price To Earning Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Pharma-Bio Serv's current stock value. Our valuation model uses many indicators to compare Pharma-Bio Serv value to that of its competitors to determine the firm's financial worth. Pharma Bio Serv is rated below average in price to earning category among its peers. It is regarded fourth in operating margin category among its peers reporting about 0.01 of Operating Margin per Price To Earning. The ratio of Price To Earning to Operating Margin for Pharma Bio Serv is roughly 165.02 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Pharma-Bio Serv's earnings, one of the primary drivers of an investment's value.Pharma-Bio Operating Margin vs. Price To Earning
Price to Earnings ratio is typically used for current valuation of a company and is one of the most popular ratios that investors monitor daily. Holding a low PE stock is less risky because when a company's profitability falls, it is likely that earnings will also go down as well. In other words, if you start from a lower position, your downside risk is limited. There are also some investors who believe that low Price to Earnings ratio reflects the low pricing because a given company is in trouble. On the other hand, a higher PE ratio means that investors are paying more for each unit of profit.
Pharma-Bio Serv |
| = | 10.00 X |
Generally speaking, the Price to Earnings ratio gives investors an idea of what the market is willing to pay for the company's current earnings.
Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
Pharma-Bio Serv |
| = | 0.06 % |
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
Pharma-Bio Operating Margin Comparison
Pharma Bio is currently under evaluation in operating margin category among its peers.
Pharma-Bio Serv Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Pharma-Bio Serv, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Pharma-Bio Serv will eventually generate negative long term returns. The profitability progress is the general direction of Pharma-Bio Serv's change in net profit over the period of time. It can combine multiple indicators of Pharma-Bio Serv, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Pharma-Bio Serv, Inc. operates as a compliance and technology transfer services consulting firm. The company was founded in 1993 and is headquartered in Dorado, Puerto Rico. Pharma Bio operates under Health Information Services classification in the United States and is traded on OTC Exchange. It employs 190 people.
Pharma-Bio Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Pharma-Bio Serv. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Pharma-Bio Serv position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Pharma-Bio Serv's important profitability drivers and their relationship over time.
Use Pharma-Bio Serv in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Pharma-Bio Serv position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pharma-Bio Serv will appreciate offsetting losses from the drop in the long position's value.Pharma-Bio Serv Pair Trading
Pharma Bio Serv Pair Trading Analysis
The ability to find closely correlated positions to Pharma-Bio Serv could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Pharma-Bio Serv when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Pharma-Bio Serv - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Pharma Bio Serv to buy it.
The correlation of Pharma-Bio Serv is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Pharma-Bio Serv moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Pharma Bio Serv moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Pharma-Bio Serv can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Pharma-Bio Serv position
In addition to having Pharma-Bio Serv in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Cash Cows Thematic Idea Now
Cash Cows
Entities with stable and reliable earnings or profits, which allows them to pay consistent dividends to their shareholders. The Cash Cows theme has 25 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Cash Cows Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Pharma-Bio OTC Stock Analysis
When running Pharma-Bio Serv's price analysis, check to measure Pharma-Bio Serv's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pharma-Bio Serv is operating at the current time. Most of Pharma-Bio Serv's value examination focuses on studying past and present price action to predict the probability of Pharma-Bio Serv's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pharma-Bio Serv's price. Additionally, you may evaluate how the addition of Pharma-Bio Serv to your portfolios can decrease your overall portfolio volatility.